Medicine News and Research

RSS

New report offers policy recommendations to combat early childhood obesity

A new national report offers policy recommendations to curb the high rates of obesity among America's youngest children.

24 Jun 2011

Potential new approach for treating myelofibrosis

A new study conducted by a team of researchers at Boston University School of Medicine (BUSM) sheds light on a possible new approach to treat the bone marrow disease known as myelofibrosis by inhibiting an enzyme that connects extracellular fibers.

24 Jun 2011

Scientists discover sleep switch in fruit fly's brain

Rather than count sheep, drink warm milk or listen to soothing music, many insomniacs probably wish for a switch they could flick to put themselves to sleep.

24 Jun 2011

Viewpoints: McKinsey report contentiousness; Medicare facts vs. beliefs; insurers' HSA 'strategy'

The White House routinely tries to intimidate its health-care critics, but the campaign against McKinsey & Co. is something else. The management consultants attempted to find out how U.S. business will respond to the government restructuring of 17.3% of the economy, Democrats don't like the results, and so McKinsey must pay with its reputation.

24 Jun 2011

Some drug mixtures may be fatal for elderly: study

British scientists warn that well known brands of hay fever tablets, painkillers and sleeping pills pose a previously unknown threat to elderly people’s health when taken together. Many are available over the counter at pharmacies as well as being prescribed by GPs, nurses and chemists they said.

23 Jun 2011

Scil Technology receives public research grant for novel rheumatoid arthritis treatments

Scil Technology GmbH, a biopharmaceutical company with core expertise in protein drug development, formulation and analytics, today announced that it has been awarded research funding by the German Federal Ministry of Education and Research (BMBF) under BMBF’s KMU-innovativ scheme. The EUR 0.9 million grant supports Scil Technology’s research program to explore the therapeutic potential of repellent proteins for the treatment of rheumatoid arthritis (RA).

23 Jun 2011

MU and Coulter Foundation enter $5 million grant agreement for biomedical research

University of Missouri officials announced today a $5 million grant agreement with the Wallace H. Coulter Foundation, through the Foundation's Translational Partnership Award Program. The goal of the partnership is to develop technologies that will save, extend and improve patient lives and suffering from any disease or condition in any country around the world.

23 Jun 2011

Funding vaccines in the developing world creates positive allies

Syndicated columnist and ONE senior adviser Michael Gerson, in a CNN opinion piece, reviews the documentary "Voodoo and Vaccines," which he writes "shows how government and health officials have reached out to religious leaders, and how many traditional healers are now carrying a pro-vaccination message.

23 Jun 2011

Resveratrol may make old age more tolerable, but not prevent it

A University of Florida review of research finds the polyphenol compound known as resveratrol found in red wine, grapes and other fruits may not prevent old age, but it might make it more tolerable.

23 Jun 2011

Proton beam radiotherapy appears to control breast cancer with minimal side-effects

A treatment that has virtually no side effects has been found to be an effective weapon for fighting early-stage breast cancer, according to results of a clinical trial conducted at Loma Linda University Medical Center.

23 Jun 2011

Developing new antipoverty vaccines may eliminate world's neglected diseases, says Sabin president

Despite significant advancements in increasing distribution and development of vaccines against childhood killer diseases - including pneumococcal disease, rotavirus, and Haemophilus influenzae Type B - global efforts to reduce the burden of infection from neglected tropical diseases (NTDs) has greatly lagged, argues Sabin Vaccine Institute (Sabin) President Dr. Peter Hotez in an article for the June edition of Health Affairs.

23 Jun 2011

Monash researchers receive MMV Project of the Year award for new anti-malarial drug candidate

Monash University is collaborating on the development of a potential new drug to cure malaria throughout the world.

23 Jun 2011

New IOM report: Decades-old health laws need to be revised

Because strong evidence indicates that policies beyond the health sector have substantial effects on people's health, all levels of U.S. government should adopt a structured approach to considering the health effects of any major legislation or regulation, says a new report by the Institute of Medicine.

23 Jun 2011

Insights into type I diabetes

A new signal pathway that renders the insulin-releasing beta cell more sensitive to high levels of blood glucose has been discovered by researchers at the Swedish medical university Karolinska Institutet. A second new study reveals a possible way to delay the disease by inhibiting a lipoprotein.

23 Jun 2011

SNP identification may help predict patients’ susceptibility to postoperative nausea and vomiting

There are several anesthetic complications that may have a hereditary background, including postoperative nausea and vomiting (PONV). Past observations have shown PONV to occur in blood relatives as far back as two to three generations.

23 Jun 2011

Summer safety tips to keep kids safe

Summer fun is in full swing, which coincides with an increase in bumps, bruises, scrapes and possibly worse. To keep kids safe, prevention and first-aid should be at the forefront of parents' minds this summer according to Dr. Karen Judy, Loyola University Health System pediatric safety expert and professor of pediatrics at Loyola University Chicago Stritch School of Medicine.

23 Jun 2011

Diamyd Medical to terminate US DiaPrevent Phase III study for type 1 diabetes

Diamyd Medical AB reports that the Company has decided to suspend dosing in a US Phase III study with the antigen-based therapy Diamyd and to initiate closure of the study.

23 Jun 2011

Unraveling molecular dysfunction due to environmental toxin exposure

In a new article published in the journal Molecular Neurodegeneration, researchers at the University of Missouri School of Medicine take some of the first steps toward unraveling the molecular dysfunction that occurs when proteins are exposed to environmental toxins. Their discovery helps further explain recent NIH findings that demonstrate the link between Parkinson's disease and two particular pesticides - rotenone and paraquat.

23 Jun 2011

CPDC, UHN to advance use of medical isotopes for cancer treatment and diagnosis

CanProbe, a unique, not-for-profit joint venture to advance the use of medical isotopes for diagnosing and treating cancer and other serious diseases, was announced today by the Centre for Probe Development and Commercialization (CPDC) and the University Health Network.

23 Jun 2011

Study examines reasons for rise in cesarean delivery

In one of the first studies to examine the reasons for the rising number of women delivering their babies by cesarean section, Yale School of Medicine researchers found that while half of the increase was attributable to a rise in repeat cesarean delivery in women with a prior cesarean birth, an equal proportion was due to a rise in first time cesarean delivery.

23 Jun 2011